Bios Clinical Opportunity Fund, LP — Form D
Bios Clinical Opportunity Fund, LP of FORT WORTH, TX, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2023-08-04. The offering totals $50.0M, of which $17.1M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-08-04
- Form: D
- Accession: 0001988639-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $50.0M
- Amount sold: $17.1M
- Remaining: $32.9M
- Investors: 20
- Date of first sale: 2023-07-12
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-488788
Issuer
- Name: Bios Clinical Opportunity Fund, LP
- CIK: 0001988639
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 1751 RIVER RUN, SUITE 400, FORT WORTH, TX, 76107
- Phone: 817-984-9197
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| - Bios Equity COF, LP | Director | Fort Worth, TX |
| Aaron GL Fletcher | Director | FORT WORTH, TX |
| John GL Fucci | Director | Fort Worth, TX |
| Aaron GL Fletcher | Executive Officer | FORT WORTH, TX |
| John GL Fucci | Executive Officer | Fort Worth, TX |
| Daniel GL Schwarz | Executive Officer | Fort Worth, TX |
| - Bios Capital Management, LP | Promoter | Fort Worth, TX |
More